SG48284A1 - Benzo-and pyridopyran deriatives having anxiolytic and anti-convulsant activity - Google Patents
Benzo-and pyridopyran deriatives having anxiolytic and anti-convulsant activityInfo
- Publication number
- SG48284A1 SG48284A1 SG1996008698A SG1996008698A SG48284A1 SG 48284 A1 SG48284 A1 SG 48284A1 SG 1996008698 A SG1996008698 A SG 1996008698A SG 1996008698 A SG1996008698 A SG 1996008698A SG 48284 A1 SG48284 A1 SG 48284A1
- Authority
- SG
- Singapore
- Prior art keywords
- pyridopyran
- deriatives
- anxiolytic
- benzo
- convulsant activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919112721A GB9112721D0 (en) | 1991-06-13 | 1991-06-13 | Novel treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
SG48284A1 true SG48284A1 (en) | 1998-04-17 |
Family
ID=10696586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG1996008698A SG48284A1 (en) | 1991-06-13 | 1992-06-11 | Benzo-and pyridopyran deriatives having anxiolytic and anti-convulsant activity |
Country Status (18)
Country | Link |
---|---|
EP (2) | EP1108718A3 (de) |
JP (3) | JP3449716B2 (de) |
KR (1) | KR100287969B1 (de) |
AT (1) | ATE213631T1 (de) |
AU (1) | AU660686B2 (de) |
CA (1) | CA2111223C (de) |
DE (1) | DE69232437T2 (de) |
DK (1) | DK0587645T3 (de) |
ES (1) | ES2173081T3 (de) |
GB (1) | GB9112721D0 (de) |
HK (1) | HK1019004A1 (de) |
IE (2) | IE20020955A1 (de) |
MX (1) | MX9202803A (de) |
NZ (2) | NZ264745A (de) |
PT (1) | PT100583B (de) |
SG (1) | SG48284A1 (de) |
WO (1) | WO1992022293A1 (de) |
ZA (1) | ZA924267B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453421A (en) * | 1992-09-11 | 1995-09-26 | E. R. Squibb & Sons, Inc. | Aryl and heterocyclic substituted propenamide derivatives |
DK0673374T3 (da) * | 1992-12-11 | 2000-07-31 | Smithkline Beecham Corp | Farmaceutisk præparat, der indeholder bicykliske forbindelsestyper |
GB9225860D0 (en) * | 1992-12-11 | 1993-02-03 | Smithkline Beecham Plc | Novel treatment |
KR100254106B1 (ko) * | 1994-06-09 | 2000-05-01 | 타이도 나오카타 | 4-퀴놀리논 유도체 또는 그의 염 |
ES2170798T3 (es) * | 1994-06-10 | 2002-08-16 | Smithkline Beecham Plc | Benzopiranos y su uso como agentes terapeuticos. |
GB9411635D0 (en) | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
AU739678B2 (en) * | 1994-06-10 | 2001-10-18 | Smithkline Beecham Plc | Benzopyrans and their use as therapeutic agents |
JPH10501256A (ja) * | 1994-06-10 | 1998-02-03 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | C−4アミド置換化合物およびその治療剤としての使用 |
GB9425502D0 (en) * | 1994-12-17 | 1995-02-15 | Smithkline Beecham Plc | Novel receptor |
US6245893B1 (en) | 1994-12-17 | 2001-06-12 | Smithkline Beecham P.L.C. | Receptor that binds anti-convulsant compounds |
US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
US5612323A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phosphinic ester substituted benzopyran derivatives |
US5612370A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phenylglycine and phenylalaninen amido benzopyran derivatives |
US5629429A (en) * | 1995-06-07 | 1997-05-13 | Bristol-Myers Squibb Company | Process for preparing 4-arylamino-benzopyran and related compounds |
GB9619492D0 (en) * | 1996-09-18 | 1996-10-30 | Smithkline Beecham Plc | Novel treatment |
DZ2446A1 (fr) * | 1997-03-18 | 2003-01-11 | Smithkline Beecham Plc | Nouveaux composés |
GB9812683D0 (en) | 1998-06-12 | 1998-08-12 | Smithkline Beecham Plc | Novel compounds |
GB9813949D0 (en) * | 1998-06-29 | 1998-08-26 | Smithkline Beecham Plc | Novel compounds |
CA2750725C (en) | 2004-01-07 | 2014-10-21 | Seikagaku Corporation | Spacer derivative for hyaluronic acid and non-steroidal anti-inflammatory drug residues |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2064514B (en) * | 1979-10-29 | 1984-01-18 | Maruko Pharmaceutical Co | Flavan compounds and acid addition salts thereof and pharmaceutical compositions thereof |
EP0126311B1 (de) * | 1983-05-18 | 1989-09-13 | Beecham Group Plc | Benzopyran-Derivate. |
EP0205292B1 (de) * | 1985-06-08 | 1991-11-06 | Beecham Group Plc | Pyrano[3,2-c]pyridinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen |
PT84806B (pt) * | 1986-05-03 | 1989-12-29 | Beecham Group Plc | Processo para a preparacao de benzopiranos |
FR2639349B1 (fr) * | 1988-11-23 | 1991-02-22 | Sanofi Sa | Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant |
-
1991
- 1991-06-13 GB GB919112721A patent/GB9112721D0/en active Pending
-
1992
- 1992-06-11 AT AT92911170T patent/ATE213631T1/de not_active IP Right Cessation
- 1992-06-11 SG SG1996008698A patent/SG48284A1/en unknown
- 1992-06-11 MX MX9202803A patent/MX9202803A/es not_active IP Right Cessation
- 1992-06-11 EP EP01200951A patent/EP1108718A3/de not_active Withdrawn
- 1992-06-11 CA CA002111223A patent/CA2111223C/en not_active Expired - Fee Related
- 1992-06-11 DK DK92911170T patent/DK0587645T3/da active
- 1992-06-11 WO PCT/GB1992/001045 patent/WO1992022293A1/en active IP Right Grant
- 1992-06-11 PT PT100583A patent/PT100583B/pt not_active IP Right Cessation
- 1992-06-11 KR KR1019930703872A patent/KR100287969B1/ko not_active IP Right Cessation
- 1992-06-11 EP EP92911170A patent/EP0587645B1/de not_active Expired - Lifetime
- 1992-06-11 JP JP51078992A patent/JP3449716B2/ja not_active Expired - Fee Related
- 1992-06-11 ES ES92911170T patent/ES2173081T3/es not_active Expired - Lifetime
- 1992-06-11 NZ NZ264745A patent/NZ264745A/en unknown
- 1992-06-11 DE DE69232437T patent/DE69232437T2/de not_active Expired - Fee Related
- 1992-06-11 AU AU18917/92A patent/AU660686B2/en not_active Ceased
- 1992-06-11 NZ NZ243108A patent/NZ243108A/en unknown
- 1992-06-11 ZA ZA924267A patent/ZA924267B/xx unknown
- 1992-07-01 IE IE20020955A patent/IE20020955A1/en not_active IP Right Cessation
- 1992-07-01 IE IE191092A patent/IE921910A1/en not_active Application Discontinuation
-
1998
- 1998-12-16 HK HK98113573A patent/HK1019004A1/xx not_active IP Right Cessation
-
2002
- 2002-01-24 JP JP2002015835A patent/JP2002255958A/ja active Pending
-
2003
- 2003-09-03 JP JP2003311700A patent/JP2004002478A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE69232437D1 (de) | 2002-04-04 |
KR940701252A (ko) | 1994-05-28 |
WO1992022293A1 (en) | 1992-12-23 |
NZ243108A (en) | 1996-08-27 |
DE69232437T2 (de) | 2002-10-31 |
ES2173081T3 (es) | 2002-10-16 |
ATE213631T1 (de) | 2002-03-15 |
EP1108718A3 (de) | 2003-02-05 |
JP2002255958A (ja) | 2002-09-11 |
AU660686B2 (en) | 1995-07-06 |
PT100583A (pt) | 1993-09-30 |
KR100287969B1 (ko) | 2001-05-02 |
CA2111223C (en) | 1998-06-09 |
JPH06507893A (ja) | 1994-09-08 |
EP0587645A1 (de) | 1994-03-23 |
JP3449716B2 (ja) | 2003-09-22 |
IE921910A1 (en) | 1992-12-16 |
ZA924267B (en) | 1993-12-10 |
EP1108718A2 (de) | 2001-06-20 |
HK1019004A1 (en) | 2000-01-14 |
CA2111223A1 (en) | 1992-12-23 |
EP0587645B1 (de) | 2002-02-27 |
DK0587645T3 (da) | 2002-06-03 |
PT100583B (pt) | 1999-07-30 |
GB9112721D0 (en) | 1991-07-31 |
JP2004002478A (ja) | 2004-01-08 |
AU1891792A (en) | 1993-01-12 |
IE20020955A1 (en) | 2003-10-01 |
NZ264745A (en) | 1997-03-24 |
MX9202803A (es) | 1992-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG48284A1 (en) | Benzo-and pyridopyran deriatives having anxiolytic and anti-convulsant activity | |
DE69327541D1 (en) | 4-arylmethyloxymethyl piperidine als tachykinin antagonisten | |
DK295888D0 (da) | Monoaminacridiner, farmaceutiske midler indeholdende disse samt anvendelse deraf til behandling af cholinerge neuronale mangeltilstande. | |
IL190780A0 (en) | Heterocyclic substituted aminoazacycles useful as central nervous system agents | |
MX9603593A (es) | Derivados de quinazolina. | |
HK1073460A1 (en) | Substituted 1, 3-oxathiolanes with antiviral properties | |
HU9401468D0 (en) | 1,3-substituted cycloalkenes and cycloalkanes | |
ES2143526T3 (es) | Derivados de amida que tienen actividad antihipercolesterolemica, su preparacion y sus usos terapeuticos. | |
HUT65574A (en) | Process for preparing 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and pharmaceutical compositions containing them | |
IL119828A0 (en) | Substituted triazine derivatives their preparation and use | |
NZ330078A (en) | Active oxygen carriers containing pterin derivatives and salts thereof for use as cosmetic agents and feed | |
FR2683819B1 (fr) | Derives de quinoleine, leur procede de preparation et leur application en therapeutique. | |
ZA972292B (en) | Cytomegalovirus inhibiting compounds. | |
EP0660822A1 (de) | Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe. | |
GB9116056D0 (en) | Compounds | |
ES8707204A1 (es) | Procedimiento para preparar diazepinoindoles | |
JO1825B1 (en) | Therapeutic agents | |
ES8702420A1 (es) | Procedimiento para la obtencion de compuestos de aminoal- quilpenem | |
JO1621B1 (en) | Therapeutic agents |